NEW YORK (GenomeWeb News) — Clinical Data today said that affiliates of company chairman RJ Kirk exercised warrants for $3.7 million in shares.
 
The purchase for 190,505 shares of the company’s common stock, valued at $19.45 a share, came from warrants issued in June 2006, the company said.
 
Clinical Data President and CEO Drew Fromkin said the cash “strengthens the company’s balance sheet and provides additional liquidity” to support the third phase of clinical trials for Vilazodone, among other projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.